What Are Wall Street Analysts' Target Price for Equifax Stock?
Equifax (EFX) stock has underperformed the broader market and its industry benchmark, with a 23.7% decline over the past year. Analysts expect EPS growth of 12.2% for the current year, with a consensus 'Moderate Buy' rating and a mean price target of $208.77, suggesting a 7.3% upside. The company's profitability has declined, with a 3.6% drop in adjusted operating margin over five years.
How this was made
The 30-second read
Why it matters
Analyst price‑target upgrades suggest a slight re‑rating but do not signal a major catalyst.
Market read
Target raise may generate modest buying pressure, but broader market drivers dominate.
What to watch
Potential regulatory scrutiny of credit‑reporting practices could cap upside.
Background
Equifax has underperformed the market in 2026, with a 10.3% decline versus the S&P 500's 11.8% rise.
Ticker impact
Analyst J.P. Morgan set a new price target of $210 for Equifax, indicating a 7.3% upside from current price.
Potential modest upside of 5‑8% over the next weeks.
Target raise is modest and reflects consensus optimism, but no new catalyst beyond the rating.
Market effects
Equifax's target raise may lift sentiment in the credit‑data sector.
Limited to US markets where credit‑reporting firms trade.
Minimal global impact beyond investors tracking US data‑services stocks.
Counterpoint
Some investors may view the modest target increase as insufficient given the stock's recent underperformance.
Key entities
- companyEquifax Inc.
US‑listed credit‑reporting and analytics firm.
- analystJ.P. Morgan
Equifax coverage firm that raised the price target.
